JPH1189512A - Health hood - Google Patents
Health hoodInfo
- Publication number
- JPH1189512A JPH1189512A JP9270669A JP27066997A JPH1189512A JP H1189512 A JPH1189512 A JP H1189512A JP 9270669 A JP9270669 A JP 9270669A JP 27066997 A JP27066997 A JP 27066997A JP H1189512 A JPH1189512 A JP H1189512A
- Authority
- JP
- Japan
- Prior art keywords
- health food
- health
- kefir
- milk
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は健康食品に関し、よ
り詳細には乳発酵産物の風味を損なうことなく、人体に
対する保健効果を総合的あるいは特異的に向上させた健
康食品に関する。TECHNICAL FIELD The present invention relates to a health food, and more particularly to a health food having a health effect on the human body which is totally or specifically improved without impairing the flavor of the fermented milk product.
【0002】[0002]
【従来の技術】近年の健康食品ブームを反映して多様な
健康食品が開発、市販されており、例えば獣乳の発酵産
物であるヨーグルトは、発酵乳のもつ保健効果への関心
の高まりと共に消費量が増大し広く摂取されている。本
発明者等は乳発酵産物の健康食品として、生理効果を有
し、保健上有効な凍結乾燥ヨーグルトとこの凍結乾燥ヨ
ーグルトを醗酵乳、ケフィアから製造する方法を開発
し、既に特開昭62−83842号公報として提案し
た。2. Description of the Related Art A variety of health foods have been developed and marketed in light of the recent health food boom. For example, yogurt, a fermented product of animal milk, is consumed with increasing interest in the health effects of fermented milk. The amount is increasing and widely consumed. The present inventors have developed a lyophilized yogurt having a physiological effect and a health effect as a health food of a fermented milk product, and a method for producing the lyophilized yogurt from fermented milk and kefir. No. 83842.
【0003】しかしながら、乳発酵産物の保健効果は、
この乳発酵産物の製造における発酵過程で使用される菌
種に由来する発酵物に影響されることが多く、自ずから
特定の効果に限定され、多様化する消費者ニューズに充
分に対応できない欠点があった。[0003] However, the health benefits of fermented milk products are:
The production of this milk fermentation product is often influenced by fermentation products derived from the bacterial species used in the fermentation process, and is naturally limited to a specific effect, and has a disadvantage that it cannot sufficiently cope with diversifying consumer news. Was.
【0004】そこで、本出願人は上記欠点を解消し、発
酵過程で用いる菌種により大きな影響を受ける乳発酵産
物の保健効果を、限られた特定の範囲から更に拡大し、
従来の乳発酵産物由来の健康食品では得られなかった人
体に対する保健効果を総合的あるいは特異的に向上させ
た健康食品として、乳発酵産物にカルシウム塩、オリゴ
糖および蜂蜜類を有効成分として含むことを特徴とする
健康食品を開発し、特開平9−37711号公報として
提案した。[0004] Accordingly, the present applicant has solved the above drawbacks, and further expanded the health effects of milk fermented products, which are greatly affected by the species used in the fermentation process, from a limited specific range.
Fermented milk products contain calcium salts, oligosaccharides and honeys as active ingredients as health foods that have not been obtained with conventional milk fermented product-derived health foods and that have improved health effects on the human body, either comprehensively or specifically. A health food characterized by the following was developed and proposed as JP-A-9-37711.
【0005】更に、本出願人は乳発酵産物を主成分、カ
ルシウム塩およびオリゴ糖を有効成分とし、核酸食品、
鮫軟骨、クロレラ、コラーゲン、アガリクス茸、シャン
ピニオンエキス、くわ茶、杜仲茶、杜仲人参茶、甜茶、
マルチビタミン剤、鉄分、大豆ペプチド、明日葉、アロ
エおよびギムネマからなる群から選ばれた少なくとも一
種を補助成分として含むことを特徴とする健康食品を開
発し、特開平9−191852号公報として提案した。Further, the applicant of the present invention has a milk fermentation product as a main component, a calcium salt and an oligosaccharide as active ingredients, and a nucleic acid food,
Shark cartilage, chlorella, collagen, agaricus mushrooms, champignon extract, kuwacha, Tochu tea, Tochu ginseng tea, Tencha,
A health food characterized by containing at least one selected from the group consisting of a multivitamin preparation, iron, soy peptide, tomorrow leaf, aloe and gymnema as an auxiliary component has been developed and proposed as Japanese Patent Application Laid-Open No. 9-191852. .
【0006】[0006]
【発明が解決しようとする課題】本発明は上記の特開平
9−37711号公報および特開平9−191852号
公報の発明を更に発展したもので、その目的は人体に対
する特有の生理活性機能をより一層向上させるととも
に、多様化する消費者ニューズにも対応した健康食品を
提供することにある。SUMMARY OF THE INVENTION The present invention is a further development of the inventions described in JP-A-9-37711 and JP-A-9-191852. It is an object of the present invention to provide health foods that can further improve and respond to diversifying consumer news.
【0007】[0007]
【課題を解決するための手段】上記の目的を達成するた
めの本発明による健康食品は、乳発酵産物を主成分とし
て、高麗人参、センナ茎、ガルシニア・カンボジア、カ
テキンおよびオオバコからなる群から選ばれた少なくと
も一種を有効成分として含むことを構成上の特徴とす
る。According to the present invention, there is provided a health food according to the present invention, which comprises a fermented milk product as a main component and is selected from the group consisting of ginseng, senna stalk, Garcinia cambodia, catechin and psyllium. The composition is characterized by containing at least one of the active ingredients as an active ingredient.
【0008】[0008]
【発明の実施の形態】本発明の健康食品における乳発酵
産物とは、獣乳すなわち牛、馬、羊、山羊などの乳の発
酵産物であり、これら獣乳から発酵産物を製造する方法
は特に限定されるものではなく、例えば牛乳を原料とす
るヨーグルトまたはケフィアの製造方法、もしくは東欧
などで行われている馬乳からの発酵産物クーミスの製造
方法などを採用することができる。乳醗酵産物としては
牛乳にケフィア菌を接種し、発酵させて得られるケフィ
アが好ましく用いられ、例えば特開昭62−83842
号公報に開示されている方法により製造することができ
る。BEST MODE FOR CARRYING OUT THE INVENTION The fermented milk product in the health food of the present invention is a fermented product of animal milk, that is, milk of cows, horses, sheep, goats and the like. The method is not limited, and for example, a method for producing yogurt or kefir using milk as a raw material, or a method for producing a fermented product Coomis from horse milk performed in Eastern Europe and the like can be employed. As the fermented milk product, kefir obtained by inoculating kefir bacteria into milk and fermenting the milk is preferably used.
Can be manufactured by the method disclosed in Japanese Patent Application Publication No.
【0009】乳発酵産物の形態としては、乳白色泥状の
いわゆるヨーグルト状、あるいはこのヨーグルト状発酵
産物を乾燥処理、例えば凍結乾燥して得られる粉末状、
またはこの粉末状発酵産物を成形して得られる顆粒状ま
たは錠剤状のいづれであってもよいが、好ましくはヨー
グルト状の発酵産物を凍結乾燥して得られる粉末状のも
のである。The fermented milk product may be in the form of a so-called yogurt in the form of a milky white mud, or a powder obtained by subjecting the yogurt-shaped fermented product to a drying treatment, for example, freeze-drying.
Alternatively, the fermentation product may be in the form of granules or tablets obtained by molding the powdery fermentation product, but is preferably in the form of a powder obtained by freeze-drying a fermentation product in the form of yogurt.
【0010】乳発酵産物の保健効果については多くの科
学的研究がなされており、古くから整腸作用、例えば胃
酸欠乏、下痢症、便秘症など胃腸の各種疾患に対する予
防や治療への効果が知られている。また、乳発酵産物は
消化管を中心とする感染防御の観点あるいは癌細胞制御
効果との関連で免疫賦活作用が示唆され、免疫応答の向
上、免疫担当細胞であるマクロファージやNK細胞の活
性化、およびこれら細胞の分化および活性化に関与する
サイトカインへの影響が明らかにされている。更に、乳
発酵産物の摂取が癌発生の抑制に効果があることが多く
の研究結果から示唆されており、抗腫瘍活性のあること
も報告されている。Many scientific studies have been conducted on the health effects of fermented milk products, and it has long been known to be effective in preventing and treating intestinal disorders such as gastrointestinal deficiency, diarrhea, and constipation. Have been. In addition, milk fermentation products have been suggested to have an immunostimulatory effect in terms of protection of infection mainly in the gastrointestinal tract or in relation to a cancer cell control effect, thereby improving the immune response and activating macrophages and NK cells, which are immunocompetent cells. And the effects on cytokines involved in the differentiation and activation of these cells have been elucidated. Furthermore, many research results have suggested that intake of milk fermentation products is effective in suppressing cancer development, and it has been reported that they have antitumor activity.
【0011】本発明の健康食品は、上記の保健効果を有
する乳発酵産物を主成分として、高麗人参、センナ茎、
ガルシニア・カンボジア、カテキンおよびオオバコから
なる群から選ばれた少なくとも一種を有効成分として含
むものでる。The health food of the present invention contains ginseng, senna stalk, ginseng fermented product having the above-mentioned health effects as a main component.
It contains at least one selected from the group consisting of Garcinia Cambodia, catechin and psyllium as an active ingredient.
【0012】高麗人参は古くから強精強壮薬として知ら
れており、ビタミンA、ビタミンC、カリウム、サポニ
ン類、プロスチゾール、ペプチド類などを主要成分とし
て含んでいる。これらの主要成分のうち、ビタミンAは
細菌に対する抵抗力増進、発育促進、視力保持、ビタミ
ンCは抗酸化作用、コレステロール値の安定、有害重金
属や発癌性物質の排除および蓄積防止、またカリウムは
体内塩分の排出などの作用を有している。更に、サポニ
ン類、すなわちRb群サポニンによる精神安定作用、血
圧降下作用、中枢神経の賦活作用が、また、プロスチゾ
ールによるDNA合成促進作用やインシュリンと同様な
作用を有するペプチドの存在も明らかになっている。高
麗人参の保健効果については未解明の点も多いが、いづ
れにしても人体の生理機能を高め強力な保健効果を有し
ていることが認められている。Ginseng has long been known as a tonic, and contains vitamin A, vitamin C, potassium, saponins, prostisol, peptides and the like as main components. Of these main components, vitamin A enhances bacterial resistance, promotes growth, maintains vision, vitamin C has antioxidant effects, stabilizes cholesterol, eliminates and prevents accumulation of harmful heavy metals and carcinogens, and potassium contains It has an effect such as discharge of salt. Furthermore, it has been revealed that saponins, ie, peptides having a tranquilizing effect, a blood pressure lowering effect, and a central nervous system activating effect by Rb group saponins, and a DNA synthesis-promoting effect of prostisol and an action similar to insulin are also present. . Although there are many unclear points about the health effects of ginseng, it has been recognized that in any case, it has a strong health effect by enhancing the physiology of the human body.
【0013】センナはアフリカを原産とする豆科の植物
で、ナイル河流域で生産されているアレキサンドリア・
センナと、インド西南部で生産されているチネンベリー
・センナの2種類があり、本発明においてはこのセンナ
の茎から抽出したエキスが用いられ、含有するセンノサ
イド成分による健康胃効果や緩下作用による便秘などへ
の保健効果が発揮される。[0013] Senna is a legume plant native to Africa and is produced in the Nile basin of Alexandria.
There are two types of senna and tinnenberry senna produced in southwest India. In the present invention, an extract extracted from the stalk of this senna is used. The health effect is exhibited for such as.
【0014】ガルシニア・カンボジアは主としてインド
に成育する植物で、その果実の抽出エキスが健康食品と
して近年注目されているものである。主成分はヒドロキ
シクエン酸であることが明らかにされ、食欲を抑制して
食品摂取量を減少させるとともに体内への脂肪吸収を妨
げるとされ、特に女性の部分痩せを可能にするとして関
心が高まっている。本発明においては、かかるガルシニ
ア・カンボジアの抽出エキスが用いられる。Garcinia cambodia is a plant that grows mainly in India, and its fruit extract has recently attracted attention as a health food. The main ingredient has been shown to be hydroxycitrate, which is believed to suppress appetite, reduce food intake, and prevent fat absorption into the body. I have. In the present invention, such an extract of Garcinia cambodia is used.
【0015】カテキンは茶の葉に含まれる水溶性成分
で、渋味があるから一般にタンニンとも呼ばれている。
茶のカテキンにはエピガロカテキンガレート、エピカテ
キン、エピカテキンガレート、エピガロカテキンなどの
種類があるが、本発明においては特定種類のカテキンに
限定されるものではなく、単一種または複数種のいづれ
であってもよい。カテキンはその化学構造にフェノール
性水酸基を複数持つのでポリフェノールとも呼ばれ、ま
た化学構造の炭素骨格部分がフラボノイド骨核と呼ばれ
るため茶フラボノイドと称せられることもある。カテキ
ンは細胞の老化につながる活性酸素に作用する抗酸化作
用があると言われ、その抗酸化作用はビタミンEの約2
0倍とされている。また、虫歯や口臭の予防に効果があ
るとされ、最近ではウイルスや細菌の感染を阻止する機
能も注目されている。本発明においては、茶葉の抽出エ
キスや乾燥物が用いられる。Catechin is a water-soluble component contained in tea leaves, and is generally called tannin because of its astringency.
Tea catechins include epigallocatechin gallate, epicatechin, epicatechin gallate, epigallocatechin and the like, but the present invention is not limited to a particular type of catechin, and any one of a single kind or a plurality of kinds may be used. It may be. Catechin is also called a polyphenol because it has a plurality of phenolic hydroxyl groups in its chemical structure, and is sometimes called a tea flavonoid because the carbon skeleton portion of the chemical structure is called a flavonoid bone nucleus. Catechin is said to have an antioxidant effect on active oxygen that leads to cell aging.
It is 0 times. In addition, it is said to be effective in preventing tooth decay and bad breath, and recently, its function of preventing infection by viruses and bacteria has attracted attention. In the present invention, an extract or dried product of tea leaves is used.
【0016】オオバコは日本全国に広く成育している雑
草で、根元に大きな葉を束生していることからオオバコ
(大葉子)の名がついたもので、3月下旬〜4月中旬か
ら夏にかけて若葉を、また開花後につける種子をそれぞ
れ採取する。葉にはプランタギニン、ホモプランタギニ
ンなどのフラボノイドとアウクビンなどを含み、種子に
はコリン、アウクビン、粘液質プランタザンなどを含ん
でいる。プランタギニンやアウクビンは喉の筋肉、食
道、気管支などの運動と分泌を支配する分泌神経を刺激
し粘液の分泌を増加して痰をきり、咳を静める作用があ
り、特に種子は利尿作用が強く腎炎などのむくみをと
り、体内老廃物である尿素、尿酸、塩化ナトリウムなど
の排泄を促進する作用がある。本発明ではかかるオオバ
コの全草を乾燥したものや、成熟種子の乾燥物、あるい
は抽出エキスが用いられる。Psyllium is a weed that grows widely throughout Japan, and has the name of Psyllium (Oyako) because it grows large leaves at the base. Late March to mid-April to summer The young leaves and the seeds to be attached after flowering are collected. The leaves contain flavonoids such as plantaginine and homoplantaginin and aucbin, and the seeds contain choline, aucbin, mucous plantazan and the like. Plantagin and augbin stimulate the secretory nerves that control the movement and secretion of the throat muscles, esophagus, bronchi, etc. It has the effect of removing swelling and promoting the excretion of urea, uric acid, sodium chloride, etc., which are body wastes. In the present invention, a dried plant of such plantain, a dried mature seed, or an extracted extract is used.
【0017】本発明の健康食品は、乳発酵産物を主成分
としてこれに高麗人参、センナ茎、ガルシニア・カンボ
ジア、カテキンおよびオオバコからなる群から選ばれた
少なくとも一種の有効成分とからなるが、更に補助成分
としてオリゴ糖を含むことが好ましい。オリゴ糖は甘味
料として種々の食品に使用されており、補助成分として
添加することにより味覚的にも優れた健康食品とするこ
とができる。また、オリゴ糖は、腸内の有用菌であるビ
フィズス菌や乳酸桿菌などの乳酸菌類やフエカリス菌の
栄養分となる増殖因子である。一方、有害菌のウェルシ
ュ菌や大腸菌、コレラ菌などの病原菌はオリゴ糖を栄養
とすることができない。従って、オリゴ糖の摂取によっ
て腸内の有用菌が増殖し、有用菌優勢の好ましい腸内環
境をつくることができる。更にオリゴ糖を分解する酵素
が腸内に乏しいので、腸から吸収されてカロリーとなる
ことは殆どない。また、オリゴ糖は糖分であるにもかか
わらず虫歯の原因であるミュータンス菌の栄養分として
は殆ど利用されることがないので虫歯の原因にはなり難
い。このため、オリゴ糖摂取により腸内での腐敗物質や
有害物質、毒素などの発生が少なくなるので、腸内が清
浄化され、毒素などを処理する肝臓の負担を軽減するこ
とができる。The health food of the present invention comprises a fermented milk product as a main component and at least one active ingredient selected from the group consisting of ginseng, senna stalk, Garcinia cambodia, catechin and psyllium. It is preferred to include oligosaccharides as auxiliary components. Oligosaccharides are used as sweeteners in various foods, and can be added to supplements to provide health foods with excellent taste. In addition, oligosaccharides are growth factors that serve as nutrients for lactic acid bacteria such as bifidobacteria and lactobacilli, which are useful bacteria in the intestine, and Fuecalis bacteria. On the other hand, pathogenic bacteria such as harmful bacteria such as C. perfringens, Escherichia coli, and V. cholerae cannot use oligosaccharides as nutrients. Therefore, the useful bacteria in the intestine grow by ingestion of the oligosaccharide, and a favorable intestinal environment in which the useful bacteria predominate can be created. In addition, since the enzyme that degrades oligosaccharides is scarce in the intestine, it is hardly absorbed into the intestine to produce calories. In addition, oligosaccharides are hardly used as nutrients of mutans bacteria, which are the cause of dental caries, even though they are sugars, and therefore are unlikely to cause dental caries. For this reason, the generation of putrefactive substances, harmful substances, toxins and the like in the intestine by ingestion of oligosaccharides is reduced, so that the intestines are cleaned and the burden on the liver for processing toxins and the like can be reduced.
【0018】本発明の健康食品の主成分である乳発酵産
物には牛乳にケフィア菌を接種し、発酵させて得られる
ケフィアが好ましく用いられる。これらの主成分と有効
成分とは目標とする保健効果に応じて、適宜選択し、組
み合わせて用いられるが、好ましい組み合わせ例として
は、主成分にケフィア、有効成分に高麗人参、主成
分にケフィア、有効成分にセンナ茎およびガルシニア・
カンボジア、主成分にケフィア、有効成分にカテキン
の組み合わせを例示することができる。As the fermented milk product which is a main component of the health food of the present invention, kefir obtained by inoculating kefir bacteria into milk and fermenting the milk is preferably used. These main component and active ingredient are appropriately selected and used in combination according to the target health effect. Examples of preferred combinations include kefir as the main ingredient, ginseng as the active ingredient, kefir as the main ingredient, Active ingredients include senna stalk and garcinia
A combination of Cambodia, kefir as a main component, and catechin as an active ingredient can be exemplified.
【0019】これらの主成分と有効成分との配合比は、
例えば乳発酵産物100重量部に対して、高麗人参では
5〜15重量部、好ましくは8〜12重量部、センナ茎
では6〜12重量部、好ましくは8〜10重量部、ガル
シニア・カンボジアでは80〜120重量部、好ましく
は90〜110重量部である。また、カテキンでは8〜
15重量部、好ましくは10〜12重量部、オオバコで
は20〜40重量部、好ましくは25〜35重量部であ
る。The mixing ratio of these main components and active ingredients is as follows:
For example, 5 to 15 parts by weight, preferably 8 to 12 parts by weight of ginseng, 6 to 12 parts by weight, preferably 8 to 10 parts by weight of senna stalk and 80 to 80 parts by weight of Garcinia Cambodia are based on 100 parts by weight of milk fermented product. To 120 parts by weight, preferably 90 to 110 parts by weight. For catechin,
The amount is 15 parts by weight, preferably 10 to 12 parts by weight, and 20 to 40 parts by weight, preferably 25 to 35 parts by weight for psyllium.
【0020】本発明の健康食品は、これらの主成分、有
効成分あるいは補助成分に加えて、通常使用される増量
剤、賦形剤、甘味料、香料などを適宜添加することがで
き、これらの各成分を充分に混和した後、粉末状、顆粒
状、錠剤状などの形態で使用に供される。更に、本発明
の健康食品を他の食品類、例えば菓子類、パン類などへ
の添加物として使用することもできる。In the health food of the present invention, in addition to these main ingredients, active ingredients or auxiliary ingredients, commonly used extenders, excipients, sweeteners, flavors and the like can be appropriately added. After the components are sufficiently mixed, they are used in the form of powder, granules, tablets and the like. Furthermore, the health food of the present invention can be used as an additive to other foods such as confectionery and bread.
【0021】[0021]
【実施例】以下、本発明の健康食品を実施例に基づいて
具体的に説明する。EXAMPLES Hereinafter, the health food of the present invention will be specifically described based on examples.
【0022】実施例1 乳発酵産物としてケフィアの凍結乾燥粉末を用い、有効
成分に高麗人参粉末を用いて下記の割合で均一に混合し
て、粉末状の健康食品を調製した。 ケフィアの凍結乾燥粉末:100g 高麗人参粉末 : 10gExample 1 A freeze-dried powder of kefir was used as a milk fermentation product, and ginseng powder was used as an active ingredient and uniformly mixed at the following ratio to prepare a powdered health food. Kefir freeze-dried powder: 100g Ginseng powder: 10g
【0023】実施例2 乳発酵産物としてケフィアの凍結乾燥粉末、有効成分に
センナ茎粉末およびガルシニア・カンボジア粉末を用い
て下記の割合で均一に混合して、粉末状の健康食品を調
製した。また、この混合粉末を成形して錠剤状の健康食
品を得た。 ケフィアの凍結乾燥粉末 :100g センナ茎粉末 : 10g ガルシニア・カンボジア粉末:100gExample 2 A powdered health food was prepared by uniformly mixing lyophilized powder of kefir as a fermented milk product and senna stalk powder and Garcinia cambodia powder as active ingredients at the following ratios. The mixed powder was molded to obtain a tablet-shaped health food. Lyophilized powder of kefir: 100 g Senna stem powder: 10 g Garcinia cambodia powder: 100 g
【0024】実施例3 乳発酵産物としてケフィアの凍結乾燥粉末、有効成分に
センナ茎粉末、ガルシニア・カンボジア粉末およびオオ
バコ粉末、更に補助成分としてオリゴ糖粉末を用いて下
記の割合で均一に混合し、混合粉末を成形して錠剤状の
健康食品を調製した。 ケフィアの凍結乾燥粉末 :100g センナ茎粉末 : 10g ガルシニア・カンボジア粉末:100g オオバコ粉末 : 30g オリゴ糖粉末 : 7gExample 3 Lyophilized powder of kefir as a fermented milk product, senna stalk powder, Garcinia cambodia powder and psyllium powder as active ingredients, and oligosaccharide powder as auxiliary ingredients were uniformly mixed in the following proportions. The mixed powder was molded to prepare a tablet-shaped health food. Kefir freeze-dried powder: 100 g Senna stem powder: 10 g Garcinia / Cambodia powder: 100 g Psyllium powder: 30 g Oligosaccharide powder: 7 g
【0025】実施例4 乳発酵産物としてケフィアの凍結乾燥粉末、有効成分に
カテキン、更に補助成分としてオリゴ糖粉末を用いて下
記の割合で均一に混合して粉末状の健康食品を調製し
た。 ケフィアの凍結乾燥粉末 :100g カテキン : 10g オリゴ糖粉末 : 10gExample 4 A freeze-dried powder of kefir as a milk fermentation product, catechin as an active ingredient, and oligosaccharide powder as an auxiliary ingredient were uniformly mixed at the following ratio to prepare a powdered health food. Lyophilized powder of kefir: 100 g Catechin: 10 g Oligosaccharide powder: 10 g
【0026】このようにして得られた健康食品は、いず
れもケフィアの有する乳状の芳香と各有効成分の生理活
性機能とが相乗的に作用して優れた保健効果を備え、ま
た喫食にも好ましいものであった。更に、オリゴ糖粉末
を添加した場合にはオリゴ糖による甘味が加わり、極め
て喫食性の優れた健康食品であった。The health foods thus obtained have excellent health effects due to the synergistic effect of the milky aroma of kefir and the physiologically active function of each active ingredient, and are also preferable for eating. Was something. Furthermore, when the oligosaccharide powder was added, the sweetness due to the oligosaccharide was added, and the health food was extremely excellent in eating ability.
【0027】[0027]
【発明の効果】本発明の健康食品は、ケフィアなどの乳
発酵産物を主成分として、高麗人参、センナ茎、ガルシ
ニア・カンボジア、カテキン、オオバコからなる群から
選ばれた少なくとも一種を有効成分として含むものであ
るから、これら各成分の有する独特の生理活性機能が相
乗的に作用して人体に対する保健効果を総合的に高める
ことができ、また、有効成分の組み合わせや配合比を変
更することにより保健効果を特異的に付与することも可
能である。更に、乳発酵産物やオリゴ糖による甘味や芳
香などの風味により幼児から老人まで容易に飲食するこ
とが可能であり、多様化する消費者ニューズに対応した
健康食品として有用である。The health food of the present invention contains as an active ingredient at least one selected from the group consisting of ginseng, senna stalk, garcinia cambodia, catechin, and psyllium, with a milk fermentation product such as kefir as a main component. Therefore, the unique physiologically active functions of each of these components act synergistically to enhance the overall health effect on the human body.Also, the health effect is improved by changing the combination and mixing ratio of the active ingredients. It is also possible to give specifically. Furthermore, it is possible to easily eat and drink from infants to the elderly by the flavors such as sweetness and aroma of fermented milk products and oligosaccharides, and it is useful as a health food corresponding to diversifying consumer news.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI A23L 2/52 A23L 2/38 P 2/38 C G A61K 31/35 // A61K 31/35 35/20 35/20 35/78 W 35/78 A23L 2/00 F ──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 6 Identification code FI A23L 2/52 A23L 2/38 P 2/38 CG A61K 31/35 // A61K 31/35 35/20 35/20 35 / 78 W 35/78 A23L 2/00 F
Claims (6)
センナ茎、ガルシニア・カンボジア、カテキンおよびオ
オバコからなる群から選ばれた少なくとも一種を有効成
分として含むことを特徴とする健康食品。1. Ginseng, comprising a milk fermented product as a main component,
A health food comprising, as an active ingredient, at least one selected from the group consisting of senna stalk, Garcinia cambodia, catechin, and psyllium.
記載の健康食品。2. The composition according to claim 1, which comprises an oligosaccharide as an auxiliary component.
Health food as described.
載の健康食品。3. The health food according to claim 1, wherein the fermented milk product is kefir.
麗人参である請求項1記載の健康食品。4. The health food according to claim 1, wherein the main component is kefir and the active ingredient is ginseng.
ンナ茎およびガルシニア・カンボジア、オオバコである
請求項1記載の健康食品。5. The health food according to claim 1, wherein the main ingredient is kefir, and the active ingredients are senna stalk, Garcinia cambodia, and plantain.
テキンである請求項1記載の健康食品。6. The health food according to claim 1, wherein the main component is kefir and the active ingredient is catechin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9270669A JPH1189512A (en) | 1997-09-17 | 1997-09-17 | Health hood |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9270669A JPH1189512A (en) | 1997-09-17 | 1997-09-17 | Health hood |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH1189512A true JPH1189512A (en) | 1999-04-06 |
Family
ID=17489306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9270669A Pending JPH1189512A (en) | 1997-09-17 | 1997-09-17 | Health hood |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH1189512A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002034069A3 (en) * | 2000-10-26 | 2003-03-13 | Banner Pharmacaps Inc | Supplement and method for nutritional supplementation of calcium, including a prophylactic motility agent |
KR100501428B1 (en) * | 2003-01-28 | 2005-07-18 | 임승수 | Processing method of goat milk and its products |
JP2011102273A (en) * | 2009-11-11 | 2011-05-26 | Shiseido Co Ltd | Tie2-activating agent, agent for maturing, normalizing or stabilizing blood vessel, lymphatic vessel-stabilizing agent, and wrinkle-preventing/ameliorating agent and dropsy-ameliorating/preventing agent |
KR101407607B1 (en) * | 2012-08-24 | 2014-06-16 | 유대용 | Preparation Method of Fermented Ginseng with high content of highfunctional ginsenoside Rg3 using Kefir, Fermented Ginseng and Fermented Ginseng Concentrate thereby |
-
1997
- 1997-09-17 JP JP9270669A patent/JPH1189512A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002034069A3 (en) * | 2000-10-26 | 2003-03-13 | Banner Pharmacaps Inc | Supplement and method for nutritional supplementation of calcium, including a prophylactic motility agent |
KR100501428B1 (en) * | 2003-01-28 | 2005-07-18 | 임승수 | Processing method of goat milk and its products |
JP2011102273A (en) * | 2009-11-11 | 2011-05-26 | Shiseido Co Ltd | Tie2-activating agent, agent for maturing, normalizing or stabilizing blood vessel, lymphatic vessel-stabilizing agent, and wrinkle-preventing/ameliorating agent and dropsy-ameliorating/preventing agent |
KR101407607B1 (en) * | 2012-08-24 | 2014-06-16 | 유대용 | Preparation Method of Fermented Ginseng with high content of highfunctional ginsenoside Rg3 using Kefir, Fermented Ginseng and Fermented Ginseng Concentrate thereby |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101898846B1 (en) | Composition of snail mucus and powder using the same | |
JPH09191852A (en) | Healthy food | |
KR101511365B1 (en) | Method of preparing functional rice using lactic-acid bacteria and wild plants | |
KR20150111724A (en) | Beverage Compositon for Animal Companhaving Antioxidant and Deodorant | |
JPH09252746A (en) | Nutrient-supplementing food | |
JP2002204669A (en) | Constipation ameliorative food containing kale processed product | |
KR101642176B1 (en) | Composition for enhancing growth and reinforcing immunity | |
JP2000166467A (en) | Health food containing fermented milk product and herbs | |
WO2007007994A1 (en) | Food composition for improving liver function comprising a lonicera caerulea l. var. edulis extract | |
KR101930433B1 (en) | manufacturing method of sweet jelly containing mealworm and sweet jelly containing mealworm made by the same | |
JPH0937711A (en) | Health food | |
WO2002041712A1 (en) | Foods containing young wheat leaf powder | |
JPH1189512A (en) | Health hood | |
CN104012605B (en) | A kind of mantis shrimp health-care fresh-preservation bread and preparation method thereof | |
JP2005237291A (en) | Health food | |
KR101700942B1 (en) | Sports beverage compositions | |
CN109481540A (en) | Composition and its preparation method and application for preventing and treating mammitis of animal | |
KR101690416B1 (en) | Method for health food using gastrodia elata, rice bran, chia seed, green tea powder | |
KR101799781B1 (en) | Method for Manufacturing Extract Powder of Cattle Bone | |
KR20190140737A (en) | Vinegar compositions comprising detox-diet material and manufacturing method thereof | |
KR102108686B1 (en) | Onion Coat Feed composition Using An Enzyme With Stevia Extract And Method thereof | |
KR20220168760A (en) | Soybean curd Having Diabetes Prevention and Blood sugar control effects producing method thereof | |
JP4084916B2 (en) | Antihypertensive food containing raw material derived from wheat | |
JP2002000226A (en) | Food containing barley young leaf powder | |
JP3648196B2 (en) | healthy food |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040823 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20050419 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050426 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050822 |